Meet Bill Karl
Director, Deloitte Consulting LLP
Bill is a director in Deloitte Consulting LLP’s (Deloitte Consulting) Life Sciences practice, focused on building and delivering Drug Safety and Regulatory consulting services and solutions. He worked in industry for 13 years before co-founding Intrasphere Technologies, which was acquired by Deloitte Consulting in 2011. He has participated in the successful delivery of complex Life Sciences pharmacovigilance and regulatory solutions for more than 25 years.
Bill is working on the next generation of drug safety and pharmacovigilance solutions, which are intended to address the needs within Life Sciences organizations as their focus extends from operational case processing, to proactive benefit /risk management, to the analytics of large scale data sources, including EHS and eventually social media. Of particular focus to Bill’s efforts is the integration of systems, both internal and external, to allow efficient and effective information flows between providers and consumers of that information.
In his leisure time, Bill enjoys hiking and vacationing in the Outer Banks. He holds a BS in Biology from Cornell.
As used in this document, "Deloitte" means Deloitte Consulting LLP, a subsidiary of Deloitte LLP. Please see www.deloitte.com/us/about for a detailed description of the legal structure of Deloitte LLP and its subsidiaries. Certain services may not be available to attest clients under the rules and regulations of public accounting.